Market Expansion Bonesupport operates in orthobiologics with CERAMENT products that address bone voids and infections, presenting opportunities to expand distribution in key markets such as Australia through partners like AKVA Surgical and further international collaborations to reach pediatric and adult orthopedic centers.

Strategic Partnerships Recent and ongoing partnerships (OrthoPediatrics distribution for pediatric hospitals, AKVA Surgical for Australia) indicate a strong channel strategy. Leverage existing alliances to accelerate market access, co-market campaigns, and regional regulatory support to boost sales.

Clinical Adoption FDA/market authorizations for CERAMENT G and expansion of indications (osteomyelitis, bone void fillers) highlight a growing clinical traction. Target hospitals and trauma centers with emphasis on osteomyelitis and complex fracture repair to drive adoption.

Revenue Growth Potential Current revenue range plus a mid-sized employee base suggests room for scaling with additional high-margin product lines and expanded product adoption across pediatrics and adult orthopedics, supported by multi-region distribution and marketing activities.

Customer Engagement Active events and Capital Markets communications indicate investor and customer visibility. Build targeted outreach to key decision-makers at trauma, orthopedics, and infection control departments, leveraging case studies and post-market outcomes to strengthen value propositions.